Sec. 501. Strategy to counter foreign adversary efforts to utilize biotechnologies in ways that threaten United States national security

282 words·~1 min read·/bill/118/s/4443/rs/section-501

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

It is the sense of Congress that as biotechnologies become increasingly important with regard to the national security interests of the United States, and with the addition of biotechnologies to the biosecurity mission of the National Counterproliferation and Biosecurity Center, the intelligence community must articulate and implement a whole-of-government strategy for addressing concerns relating to biotechnologies. Not later than 90 days after the date of the enactment of this Act, the Director of National Intelligence shall, acting through the Director of the National Counterproliferation and Biosecurity Center and in coordination with the heads of such other elements of the intelligence community as the Director of National Intelligence considers appropriate, develop and submit to the congressional intelligence committees a whole-of-government strategy to address concerns relating to biotechnologies.

The strategy developed and submitted pursuant to paragraph

(1)shall include the following: Identification and assessment of biotechnologies critical to the national security of the United States, including an assessment of which materials involve a dependency on foreign adversary nations. A determination of how best to counter foreign adversary efforts to utilize biotechnologies that threaten the national security of the United States, including technologies identified pursuant to paragraph (1). A plan to support United States efforts and capabilities to secure the United States supply chains of the technologies identified pursuant to paragraph (1), by coordinating— across the intelligence community; the support provided by the intelligence community to other relevant Federal agencies and policymakers; the engagement of the intelligence community with private sector entities; and how the intelligence community can support securing United States supply chains for and use of biotechnologies. Proposals for such legislative or administrative action as the Directors consider necessary to support the strategy.